NOK 2.44
(-0.61%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | - NOK | 0.0% |
2022 | - NOK | 0.0% |
2021 | - NOK | -100.0% |
2020 | 2.35 Million NOK | -48.46% |
2019 | 4.57 Million NOK | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | - NOK | 0.0% |
2024 Q1 | - NOK | 0.0% |
2023 FY | - NOK | 0.0% |
2023 Q4 | - NOK | 0.0% |
2023 Q2 | - NOK | 0.0% |
2023 Q1 | - NOK | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Arctic Bioscience AS | 2.04 Million NOK | 100.0% |
Aqua Bio Technology ASA | - NOK | NaN% |
ArcticZymes Technologies ASA | 8.41 Million NOK | 100.0% |
BerGenBio ASA | - NOK | NaN% |
Hofseth BioCare ASA | 97.1 Million NOK | 100.0% |
PCI Biotech Holding ASA | - NOK | NaN% |
Ultimovacs ASA | 1.88 Million NOK | 100.0% |